期刊
BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES
卷 53, 期 2, 页码 -出版社
UNIV SAO PAULO, CONJUNTO QUIMICAS
DOI: 10.1590/s2175-97902017000216105
关键词
FLT3-ITD/mutation; Acute leucemia/prognostic factors; Acute leucemia/adults patients; Acute leucemia/pediatric patients; AML; ALL; FLT3-D835
资金
- National Counsel of Technological and Scientific Development - CNPq (Brazil)
- Coordination for the Improvement of Higher Education Personnel - CAPES (Brazil)
- Fundacao de Amparo a Pesquisa e Inovacao do Estado de Santa Catarina - FAPESC
When the FLT3 gene is mutated, it originates a modified receptor with structural changes, which give survival advantage and malignant hematopoietic cell proliferation. Thus, the presence of mutations in this gene is considered an unfavorable prognostic factor. A total of 85 consecutive samples of newly diagnosed untreated patients with AL were included in the study after they provided their informed consent. FLT3 gene mutations were detected by PCR. For the pediatric group, a positive correlation was observed between WBC count and the presence of FLT3-ITD in patients with AML and ALL. Furthermore, children with AML who had the FLT3-ITD mutation showed a tendency to express CD34 in blast cells. In the adult group, the AML patients with FLT3-ITD who expressed CD34 in blast cells had a tendency to worse progression. The present data indicate no association between the prognostic factors evaluated and FLT3 gene mutations in adult with AL. Yet, the presence of FLT3-ITD mutation was significantly related with WBC count in the pediatric group. These findings demonstrate that FLT3 gene mutations can be considered as independent poor prognostic factors.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据